... more >>
Practical Education and Resources
In May 2011, the FDA ... more >>
This year's state-of-the-science curriculum features the very latest information on screening and ... more >>
Assess the efficacy and safety of these agents in treatment-naive, relapsing, and nonresponder patients.
Anticipate and embrace these new models of care, and ... more >>